These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 10140721

  • 1. Cough up that cash.
    Farley CJ.
    Time; 1995 Mar 06; 145(9):47. PubMed ID: 10140721
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Smoke and mirrors: Florida's tobacco-related Medicaid costs may turn out to be a mirage.
    May C.
    Spec Law Dig Health Care Law; 1998 Mar 06; (228):9-38. PubMed ID: 10177499
    [No Abstract] [Full Text] [Related]

  • 4. Perspectives. Battle heats up over product liability reform.
    Miller D.
    Faulkner Grays Med Health; 1995 Apr 24; 49(17):suppl 1-4. PubMed ID: 10141116
    [No Abstract] [Full Text] [Related]

  • 5. Medical devices; preemption of state product liability claims--FDA. Correction.
    Fed Regist; 1997 Dec 17; 62(242):66179. PubMed ID: 10179302
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Medical devices; preemption of state product liability claims--FDA. Proposed rule.
    Fed Regist; 1997 Dec 12; 62(239):65384-8. PubMed ID: 10176832
    [Abstract] [Full Text] [Related]

  • 8. Attitudes of the Wisconsin State Legislature toward tobacco control policies.
    Gifford R, Brindley MS.
    Wis Med J; 1994 Nov 12; 93(11):582-4. PubMed ID: 7825335
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmaceutical industry wins "round one" in protections against product liability claims.
    Gatty B.
    Hosp Formul; 1995 Apr 12; 30(4):238, 237. PubMed ID: 10141868
    [No Abstract] [Full Text] [Related]

  • 11. The Lohr decision: FDA perspective and position.
    Porter MJ.
    Food Drug Law J; 1997 Apr 12; 52(1):7-11. PubMed ID: 10346705
    [No Abstract] [Full Text] [Related]

  • 12. Legal developments in healthcare.
    Holubitsky DJ.
    Leadersh Health Serv; 1996 Apr 12; 5(4):30-3. PubMed ID: 10159552
    [Abstract] [Full Text] [Related]

  • 13. Grandfathering can seriously damage your wealth: due diligence in mergers and acquisitions of medical device companies.
    Brown WM.
    Spec Law Dig Health Care Law; 2002 Nov 12; (283):9-42. PubMed ID: 12506606
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. License to maim: federal pre-emption and the Medical Device Amendments of 1976.
    Petrella ME.
    Health Matrix Clevel; 1996 Nov 12; 6(2):349-89. PubMed ID: 10178392
    [No Abstract] [Full Text] [Related]

  • 17. King v. Collagen Corporation: FDA approval insulates medical device manufacturers from state common law liability.
    Kronenberg AW.
    J Contemp Health Law Policy; 1995 Nov 12; 11(2):563-87. PubMed ID: 10184353
    [No Abstract] [Full Text] [Related]

  • 18. Tobacco control implications of the first European product liability suit.
    Hiilamo HT.
    Tob Control; 2005 Feb 12; 14(1):22-30. PubMed ID: 15735296
    [Abstract] [Full Text] [Related]

  • 19. Greater and lesser powers of tort reform: the primary jurisdiction doctrine and state-law claims concerning FDA-approved products.
    Struve CT.
    Cornell Law Rev; 2008 Jul 12; 93(5):1039-74. PubMed ID: 18618970
    [No Abstract] [Full Text] [Related]

  • 20. Medical device preemption after Medtronic, Inc. v. Lohr.
    Neraas MB.
    Food Drug Law J; 1996 Jul 12; 51(4):619-29. PubMed ID: 11797731
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.